Abstract: Midostaurin was a prototype kinase inhibitor. originally developed as a protein kinase C inhibitor and subsequently as an angiogenesis inhibitor. based on its inhibition of vascular endothelial growth factor receptor. Despite promising preclinical data. https://www.ivoryjinelle.com/